Objective: To compare the efficacy and safety of the levonorgestrel-releasing intrauterine device (LNG-IUD) with dydrogesterone applied for the same duration in patients having endometrial hyperplasia (EH) without atypia.
Materials And Methods: One hundred thirty eight women aged between 30 and 50 years with abnormal uterine bleeding and diagnosed as EH by transvaginal ultrasound were randomized to receive either LNG-IUD or dydrogesterone for 6 months. Primary outcome measures were regression of hyperplasia after 6 months of therapy.
Objective: To evaluate the diagnostic accuracy of lactate dehydrogenase (LD) isoenzyme activity profile in uterine fluid and transvaginal ultrasound (TVS) in detection of endometrial cancer in women with postmenopausal bleeding.
Study Design: Prospective controlled clinical study.
Methods: One hundred twenty postmenopausal women with one or more episode of vaginal bleeding were studied.